US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

OS Therapies

1.79

+0.00930.52%

Volume:139.39K

Turnover:249.22K

Market Cap:83.15M

PE:-1.70

High:1.82

Open:1.81

Low:1.76

Close:1.78

52wk High:2.28

52wk Low:1.15

Shares:46.47M

Float Shares:33.71M

Volume Ratio:1.45

T/O Rate:0.41%

Dividend:- -

Dividend Rate:- -

EPS(TTM):-1.0524

EPS(LYR):-0.9829

ROE:-914.04%

ROA:-232.65%

PB:-6.98

PE(LYR):-1.82

Loading ...

Overview Company News Filings

OS Therapies Agrees to Repay Leonite Debt in USD 1.9 Million Cash Settlement

OS Therapies - Terminates at Market Issuance Sales Agreement on July 23, 2026 - SEC Filing

OS Therapies Ends At-The-Market Equity Sales Program

Os Therapies - Termination of Sales Agreement Effective July 28, 2026 - SEC Filing

THOMSON REUTERS

OS Therapies Announces Annual Shareholder Meeting

OS Therapies Files Form 3 Showing Director Craig Eagle Holds no Securities

OS Therapies Initiated at Buy by Roth Capital

OS Therapies initiated with a Buy at Roth Capital

OS Therapies Accepts FDA CDER Meeting Request to Review Ost-her2 Biomarker Data

OS Therapies Amends 8-K to Add Side Letter Tied to Leonite Private Placement

OS Therapies Incorporated (OSTX) Gets a Buy from Lake Street

OS Therapies Enters USD 10 Million Line of Credit Backed by U.K. VAT, R&D Tax Credits

OS Therapies Secures Convertible Note Financing for Expansion

Os Therapies - Enters Agreement for up to $10 Mln Senior Secured Convertible Note on June 30- SEC Filing

THOMSON REUTERS

OS Therapies Names Chief Medical Advisor Craig Eagle to Board

OS Therapies Seeks FDA Alignment on 3-year Overall Survival Endpoint for Ost-her2 Accelerated Approval Bid

OS Therapies Unit OS Animal Health Posts Peer-reviewed Data for Ost-her2 in Canine Osteosarcoma Trial

Wall Street Analysts Are Bullish on Top Healthcare Picks

OS Therapies says OST-HER2 Phase 2b trial posts 75% 2.5-year survival in resected metastatic osteosarcoma

OS Therapies to release 2.5-year overall survival data from Phase 2b OST-HER2 osteosarcoma trial at ASCO 2026

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Easy breezy. No more feesies.","description":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","keywords":"Tiger Brokers,U.S. stock trading,Hong Kong stock trading,trading U.S. stocks,stock information,stock prices,U.S. stock quotes,U.S. stock trading,Hong Kong stock trading,IPO trading,buying U.S. stocks,global investment","social":{"ogDescription":"Tiger Trade is a mobile trading app offering real time data, low commission fees and a free demo account. Download now to start investing in ETFs, options and the global share market.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.thetigerbrokers.com/stock/OSTX/news?page=2"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"NZL","license":"TBKIWI","edition":"fundamental","symbol":"OSTX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OSTX\",,,,,undefined,":{"symbol":"OSTX","market":"US","secType":"STK","nameCN":"OS Therapies","latestPrice":1.7893,"timestamp":1789568228205,"preClose":1.78,"halted":0,"volume":139388,"delay":0,"changeRate":0.005224719101123519,"floatShares":33708100,"shares":46470790,"eps":-1.05241,"marketStatus":"Trading","change":0.0093,"latestTime":"09-16 10:18:25 EDT","open":1.81,"high":1.82,"low":1.76,"amount":249218.60733439997,"amplitude":0.033708,"askPrice":1.79,"askSize":300,"bidPrice":1.77,"bidSize":301,"shortable":3,"etf":0,"ttmEps":-1.05241,"tradingStatus":2,"nextMarketStatus":{"tag":"Post-Mkt","tradingStatus":3,"beginTime":1789588800000},"marketStatusCode":2,"adr":0,"listingDate":1719460800000,"exchange":"AMEX","adjPreClose":1.78,"preHourTrading":{"tag":"盘前","latestPrice":1.79,"preClose":1.78,"latestTime":"09:21 EDT","volume":1003,"amount":1793.390078,"timestamp":1789564862727,"change":0.01,"changeRate":0.005618,"amplitude":0.022472},"postHourTrading":{"tag":"盘后","latestPrice":1.75,"preClose":1.78,"latestTime":"19:30 EDT","volume":3622,"amount":6390.2882,"timestamp":1789515006205,"change":-0.03,"changeRate":-0.016854,"amplitude":0.033034},"volumeRatio":1.454103},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OSTX\",,,,,undefined,":{"symbol":"OSTX","floatShares":33708100,"roa":"-232.65%","roe":"-914.04%","lyrEps":-0.982926,"volumeRatio":1.454103,"shares":46470790,"dividePrice":0,"high":1.82,"amplitude":0.033708,"preClose":1.78,"low":1.76,"week52Low":1.15,"pbRate":"-6.98","week52High":2.28,"institutionHeld":0,"latestPrice":1.7893,"committee":0.001664,"eps":-1.05241,"divideRate":0,"volume":139388,"delay":0,"ttmEps":-1.05241,"open":1.81,"prevYearClose":1.4,"prevWeekClose":1.68,"prevMonthClose":1.69,"prevQuarterClose":1.9,"fiveDayClose":1.86,"twentyDayClose":1.44,"sixtyDayClose":1.82},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OSTX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OSTX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OSTX\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0,"buy":1,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":1,"analysts":4,"updateTime":1783656000000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OSTX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OSTX","date":"2026-09-15","current":-1.691356,"percent":0.932584,"low":-14.897496,"twenty":-7.50649,"median":-4.375967,"eighty":-2.444133,"high":-1.629046,"avg":-5.111486,"sd":3.235544,"marketCap":78413902},"quantilePoints":[{"date":"2024-06-14","current":-13.217965,"twenty":-13.216533,"median":-13.214385,"eighty":-13.212238,"marketCap":102988885},{"date":"2024-06-21","current":-10.574372,"twenty":-13.217965,"median":-13.214385,"eighty":-12.156232,"marketCap":82391108},{"date":"2024-06-28","current":-13.217965,"twenty":-13.217965,"median":-13.217965,"eighty":-13.210806,"marketCap":102988885},{"date":"2024-08-02","current":-6.458845,"twenty":-13.217965,"median":-13.217965,"eighty":-11.101659,"marketCap":50324634},{"date":"2024-08-09","current":-8.117559,"twenty":-13.217965,"median":-10.433676,"eighty":-8.215548,"marketCap":63248641},{"date":"2024-08-16","current":-10.993719,"twenty":-13.216533,"median":-10.29298,"eighty":-8.15204,"marketCap":70975778},{"date":"2024-08-23","current":-13.004275,"twenty":-13.182439,"median":-10.833368,"eighty":-8.309008,"marketCap":83955991},{"date":"2024-08-30","current":-11.710317,"twenty":-13.188909,"median":-11.710317,"eighty":-8.610078,"marketCap":75602161},{"date":"2024-09-06","current":-12.939577,"twenty":-13.217965,"median":-12.391225,"eighty":-8.620371,"marketCap":83538300},{"date":"2024-09-13","current":-11.32213,"twenty":-13.217965,"median":-12.261039,"eighty":-9.289415,"marketCap":73096012},{"date":"2024-09-20","current":-11.483875,"twenty":-13.217965,"median":-11.710317,"eighty":-10.29298,"marketCap":74140241},{"date":"2024-09-27","current":-9.575287,"twenty":-13.210806,"median":-11.435351,"eighty":-9.575287,"marketCap":61818342},{"date":"2024-10-04","current":-9.727327,"twenty":-13.101322,"median":-11.354479,"eighty":-9.316172,"marketCap":62799917},{"date":"2024-10-11","current":-9.931126,"twenty":-13.068973,"median":-11.192735,"eighty":-9.413543,"marketCap":64115645},{"date":"2024-10-18","current":-9.769381,"twenty":-13.068973,"median":-10.859351,"eighty":-9.542938,"marketCap":63071416},{"date":"2024-10-25","current":-9.413543,"twenty":-13.004275,"median":-10.610453,"eighty":-9.542938,"marketCap":60774113},{"date":"2024-10-31","current":-8.782738,"twenty":-12.952517,"median":-10.592413,"eighty":-9.394069,"marketCap":56701621},{"date":"2024-11-08","current":-9.085848,"twenty":-12.836061,"median":-10.29298,"eighty":-9.218608,"marketCap":58658505},{"date":"2024-11-15","current":-7.116768,"twenty":-12.603148,"median":-10.141393,"eighty":-8.950952,"marketCap":45946065},{"date":"2024-11-22","current":-5.272053,"twenty":-12.423258,"median":-9.769381,"eighty":-8.605027,"marketCap":38782655},{"date":"2024-11-29","current":-6.178419,"twenty":-12.235002,"median":-9.759676,"eighty":-8.507772,"marketCap":45450128},{"date":"2024-12-06","current":-5.370028,"twenty":-11.917351,"median":-9.716005,"eighty":-8.143742,"marketCap":39503383},{"date":"2024-12-13","current":-12.876517,"twenty":-11.917351,"median":-9.704683,"eighty":-7.804035,"marketCap":94723165},{"date":"2024-12-20","current":-11.288606,"twenty":-11.937313,"median":-9.73218,"eighty":-8.125896,"marketCap":83042057},{"date":"2024-12-27","current":-14.738704,"twenty":-12.001827,"median":-9.761941,"eighty":-8.139646,"marketCap":108421919},{"date":"2025-01-03","current":-12.068126,"twenty":-12.384347,"median":-9.850254,"eighty":-8.168424,"marketCap":88776420},{"date":"2025-01-10","current":-14.782011,"twenty":-12.810182,"median":-10.086184,"eighty":-8.234384,"marketCap":108740495},{"date":"2025-01-17","current":-11.8949,"twenty":-12.876517,"median":-10.189917,"eighty":-8.475423,"marketCap":87502117},{"date":"2025-01-24","current":-8.430366,"twenty":-12.823449,"median":-10.125219,"eighty":-8.466412,"marketCap":62016063},{"date":"2025-01-31","current":-5.629868,"twenty":-12.632281,"median":-9.850254,"eighty":-8.128675,"marketCap":41414837},{"date":"2025-02-07","current":-5.600996,"twenty":-12.558673,"median":-9.759676,"eighty":-7.471942,"marketCap":41202453},{"date":"2025-02-14","current":-5.745352,"twenty":-12.423258,"median":-9.716005,"eighty":-6.985183,"marketCap":42264372},{"date":"2025-02-21","current":-5.456641,"twenty":-12.370592,"median":-9.688508,"eighty":-6.36129,"marketCap":40140534},{"date":"2025-02-28","current":-4.734863,"twenty":-12.322192,"median":-9.575287,"eighty":-6.039722,"marketCap":34830939},{"date":"2025-03-07","current":-4.850347,"twenty":-12.19815,"median":-9.413543,"eighty":-5.818713,"marketCap":35680475},{"date":"2025-03-14","current":-4.619378,"twenty":-12.093217,"median":-9.316172,"eighty":-5.658739,"marketCap":33981404},{"date":"2025-03-21","current":-4.590507,"twenty":-12.033481,"median":-9.267973,"eighty":-5.589448,"marketCap":33769021},{"date":"2025-03-28","current":-4.677121,"twenty":-11.941094,"median":-9.085848,"eighty":-5.445093,"marketCap":34406172},{"date":"2025-04-04","current":-3.682014,"twenty":-11.842932,"median":-9.000397,"eighty":-5.346931,"marketCap":32707102},{"date":"2025-04-11","current":-2.731469,"twenty":-11.788323,"median":-8.747948,"eighty":-5.012916,"marketCap":24263468},{"date":"2025-04-17","current":-3.828934,"twenty":-11.749136,"median":-8.669517,"eighty":-4.901959,"marketCap":34012183},{"date":"2025-04-25","current":-3.926486,"twenty":-11.61974,"median":-8.601309,"eighty":-4.833024,"marketCap":34878735},{"date":"2025-05-02","current":-4.706906,"twenty":-11.475058,"median":-8.516979,"eighty":-4.792605,"marketCap":41811155},{"date":"2025-05-09","current":-4.804459,"twenty":-11.45771,"median":-8.491597,"eighty":-4.792605,"marketCap":42677707},{"date":"2025-05-16","current":-4.048427,"twenty":-11.438586,"median":-8.234384,"eighty":-4.718089,"marketCap":35961926},{"date":"2025-05-23","current":-2.933033,"twenty":-11.406237,"median":-8.124506,"eighty":-4.677121,"marketCap":33145630},{"date":"2025-05-30","current":-3.928425,"twenty":-11.380358,"median":-7.63641,"eighty":-4.64825,"marketCap":44394361},{"date":"2025-06-06","current":-4.052742,"twenty":-11.348009,"median":-7.333748,"eighty":-4.596281,"marketCap":45799246},{"date":"2025-06-13","current":-4.574874,"twenty":-11.315425,"median":-7.167274,"eighty":-4.590507,"marketCap":51699762},{"date":"2025-06-20","current":-4.525147,"twenty":-11.288606,"median":-6.448552,"eighty":-4.525147,"marketCap":51137808},{"date":"2025-06-27","current":-4.500284,"twenty":-11.257432,"median":-6.245836,"eighty":-4.450557,"marketCap":50856831},{"date":"2025-07-03","current":-4.804944,"twenty":-11.153916,"median":-6.178419,"eighty":-4.480042,"marketCap":54299732},{"date":"2025-07-11","current":-4.384839,"twenty":-11.071717,"median":-6.001438,"eighty":-4.444649,"marketCap":49552214},{"date":"2025-07-18","current":-4.411096,"twenty":-11.057637,"median":-5.848373,"eighty":-4.413618,"marketCap":49848934},{"date":"2025-07-25","current":-5.118748,"twenty":-11.006503,"median":-5.726085,"eighty":-4.413618,"marketCap":57845975},{"date":"2025-08-01","current":-5.266689,"twenty":-10.886225,"median":-5.658739,"eighty":-4.423405,"marketCap":59517824},{"date":"2025-08-08","current":-5.177924,"twenty":-10.817778,"median":-5.632611,"eighty":-4.43502,"marketCap":58514715},{"date":"2025-08-15","current":-6.36145,"twenty":-10.649839,"median":-5.600996,"eighty":-4.43838,"marketCap":71889507},{"date":"2025-08-22","current":-5.360009,"twenty":-10.610453,"median":-5.567348,"eighty":-4.444649,"marketCap":76540639},{"date":"2025-08-29","current":-5.047341,"twenty":-10.610453,"median":-5.538676,"eighty":-4.449676,"marketCap":72075768},{"date":"2025-09-05","current":-4.667674,"twenty":-10.601601,"median":-5.456641,"eighty":-4.458388,"marketCap":66654139},{"date":"2025-09-12","current":-5.119065,"twenty":-10.582903,"median":-5.4212,"eighty":-4.477891,"marketCap":73099984},{"date":"2025-09-19","current":-4.897461,"twenty":-10.460155,"median":-5.370028,"eighty":-4.495136,"marketCap":69935483},{"date":"2025-09-26","current":-4.675856,"twenty":-10.329392,"median":-5.362697,"eighty":-4.515202,"marketCap":66770981},{"date":"2025-10-03","current":-4.409931,"twenty":-10.231142,"median":-5.325865,"eighty":-4.459866,"marketCap":62973579},{"date":"2025-10-10","current":-4.520733,"twenty":-10.170508,"median":-5.292169,"eighty":-4.471291,"marketCap":64555830},{"date":"2025-10-17","current":-4.099684,"twenty":-10.138159,"median":-5.266689,"eighty":-4.443146,"marketCap":58543277},{"date":"2025-10-24","current":-4.250282,"twenty":-10.078376,"median":-5.177924,"eighty":-4.421116,"marketCap":60693806},{"date":"2025-10-31","current":-4.156353,"twenty":-9.977535,"median":-5.177924,"eighty":-4.412988,"marketCap":59352507},{"date":"2025-11-07","current":-4.273765,"twenty":-9.834079,"median":-5.118748,"eighty":-4.402429,"marketCap":61029131},{"date":"2025-11-14","current":-4.273765,"twenty":-9.766275,"median":-5.104544,"eighty":-4.391176,"marketCap":61029131},{"date":"2025-11-21","current":-2.971008,"twenty":-9.761488,"median":-5.059977,"eighty":-4.38129,"marketCap":54322633},{"date":"2025-11-28","current":-3.447432,"twenty":-9.750618,"median":-5.0362,"eighty":-4.358965,"marketCap":63033690},{"date":"2025-12-05","current":-3.50521,"twenty":-9.73315,"median":-4.994703,"eighty":-4.321289,"marketCap":64090120},{"date":"2025-12-12","current":-3.909657,"twenty":-9.718269,"median":-4.969558,"eighty":-4.300776,"marketCap":71485134},{"date":"2025-12-19","current":-3.081503,"twenty":-9.704683,"median":-4.950787,"eighty":-4.273765,"marketCap":56342963},{"date":"2025-12-26","current":-2.927428,"twenty":-9.698213,"median":-4.936226,"eighty":-4.231496,"marketCap":53525815},{"date":"2026-01-02","current":-2.696315,"twenty":-9.672334,"median":-4.919621,"eighty":-4.226786,"marketCap":49300092},{"date":"2026-01-09","current":-2.965947,"twenty":-9.672334,"median":-4.910716,"eighty":-4.157441,"marketCap":54230102},{"date":"2026-01-16","current":-2.811872,"twenty":-9.575287,"median":-4.897871,"eighty":-4.145979,"marketCap":51412953},{"date":"2026-01-23","current":-2.831131,"twenty":-9.549408,"median":-4.897461,"eighty":-4.087363,"marketCap":51765097},{"date":"2026-01-30","current":-2.657797,"twenty":-9.439422,"median":-4.891008,"eighty":-3.973179,"marketCap":48595805},{"date":"2026-02-06","current":-2.445943,"twenty":-9.413543,"median":-4.875301,"eighty":-3.908145,"marketCap":44722227},{"date":"2026-02-13","current":-2.23409,"twenty":-9.413543,"median":-4.874269,"eighty":-3.823969,"marketCap":40848648},{"date":"2026-02-20","current":-2.311128,"twenty":-9.35512,"median":-4.850347,"eighty":-3.774842,"marketCap":42257222},{"date":"2026-02-27","current":-2.754094,"twenty":-9.300118,"median":-4.8312,"eighty":-3.691488,"marketCap":50356523},{"date":"2026-03-06","current":-2.908169,"twenty":-9.286254,"median":-4.804944,"eighty":-3.509217,"marketCap":53173671},{"date":"2026-03-13","current":-2.927428,"twenty":-9.264738,"median":-4.804459,"eighty":-3.458987,"marketCap":53525815},{"date":"2026-03-20","current":-2.888909,"twenty":-9.232389,"median":-4.792605,"eighty":-3.347283,"marketCap":52821528},{"date":"2026-03-27","current":-2.638537,"twenty":-9.139288,"median":-4.763734,"eighty":-3.283217,"marketCap":48243662},{"date":"2026-04-02","current":-1.869843,"twenty":-9.07459,"median":-4.734863,"eighty":-3.19573,"marketCap":53765188},{"date":"2026-04-10","current":-1.973708,"twenty":-9.037738,"median":-4.706449,"eighty":-3.15544,"marketCap":56751705},{"date":"2026-04-17","current":-2.046809,"twenty":-9.001875,"median":-4.699192,"eighty":-3.081503,"marketCap":58853620},{"date":"2026-04-24","current":-2.119909,"twenty":-8.908899,"median":-4.683564,"eighty":-3.034837,"marketCap":60955535},{"date":"2026-05-01","current":-2.485411,"twenty":-8.768822,"median":-4.677121,"eighty":-2.985206,"marketCap":71465110},{"date":"2026-05-08","current":-2.485411,"twenty":-8.7364,"median":-4.657962,"eighty":-2.965947,"marketCap":71465110},{"date":"2026-05-15","current":-2.748572,"twenty":-8.699253,"median":-4.619378,"eighty":-2.954392,"marketCap":79032004},{"date":"2026-05-22","current":-2.169023,"twenty":-8.649859,"median":-4.610947,"eighty":-2.927428,"marketCap":76509706},{"date":"2026-05-29","current":-2.500026,"twenty":-8.617798,"median":-4.590507,"eighty":-2.912021,"marketCap":88185449},{"date":"2026-06-05","current":-2.335883,"twenty":-8.605027,"median":-4.574874,"eighty":-2.888909,"marketCap":82395496},{"date":"2026-06-12","current":-2.159113,"twenty":-8.590585,"median":-4.542637,"eighty":-2.850391,"marketCap":76160161},{"date":"2026-06-18","current":-2.17174,"twenty":-8.57247,"median":-4.525147,"eighty":-2.831131,"marketCap":76605542},{"date":"2026-06-26","current":-2.272751,"twenty":-8.516979,"median":-4.520733,"eighty":-2.811872,"marketCap":80168590},{"date":"2026-07-02","current":-2.285377,"twenty":-8.509613,"median":-4.508587,"eighty":-2.790024,"marketCap":80613971},{"date":"2026-07-10","current":-2.17174,"twenty":-8.507772,"median":-4.481912,"eighty":-2.769501,"marketCap":76605542},{"date":"2026-07-17","current":-1.893959,"twenty":-8.481893,"median":-4.461622,"eighty":-2.745824,"marketCap":66807159},{"date":"2026-07-24","current":-1.969717,"twenty":-8.439377,"median":-4.448354,"eighty":-2.715575,"marketCap":69479445},{"date":"2026-07-31","current":-1.969717,"twenty":-8.312777,"median":-4.438389,"eighty":-2.696315,"marketCap":69479445},{"date":"2026-08-07","current":-2.058102,"twenty":-8.184914,"median":-4.437352,"eighty":-2.657797,"marketCap":72597112},{"date":"2026-08-14","current":-2.020223,"twenty":-8.139646,"median":-4.419971,"eighty":-2.618363,"marketCap":71260969},{"date":"2026-08-21","current":-1.787426,"twenty":-8.123117,"median":-4.411096,"eighty":-2.573055,"marketCap":70370207},{"date":"2026-08-28","current":-1.968306,"twenty":-7.906822,"median":-4.400554,"eighty":-2.529271,"marketCap":77491386},{"date":"2026-09-04","current":-2.132332,"twenty":-7.610426,"median":-4.389861,"eighty":-2.500031,"marketCap":83949001},{"date":"2026-09-11","current":-2.132332,"twenty":-7.50649,"median":-4.384839,"eighty":-2.485411,"marketCap":83949001},{"date":"2026-09-15","current":-1.991738,"twenty":-7.50649,"median":-4.375967,"eighty":-2.444133,"marketCap":78413902}],"updateTime":1789568305891},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OSTX\",pageSize:20,pageCount:2,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2657665409","title":"OS Therapies Agrees to Repay Leonite Debt in USD 1.9 Million Cash Settlement","url":"https://stock-news.laohu8.com/highlight/detail?id=2657665409","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2657665409?lang=en_us&edition=fundamental","pubTime":"2026-08-07 05:18","pubTimestamp":1786051088,"startTime":"0","endTime":"0","summary":"OS Therapies agrees to repay Leonite debt in USD 1.9 million cash settlementOS Therapies reached a settlement to repay and terminate its Leonite senior secured convertible promissory note.Settlement c","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260806:nNDL4SZrYJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655151817","title":"OS Therapies - Terminates at Market Issuance Sales Agreement on July 23, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2655151817","media":"Reuters","labels":["shareholding","express"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655151817?lang=en_us&edition=fundamental","pubTime":"2026-07-30 06:11","pubTimestamp":1785363104,"startTime":"0","endTime":"0","summary":"BRIEF-OS Therapies - Terminates At Market Issuance Sales Agreement On July 23, 2026 - SEC FilingJuly 29 -OS Therapies IncOSTX.A:OS THERAPIES - TERMINATES AT MARKET ISSUANCE SALES AGREEMENT ON JULY 23, 2026 - SEC FILINGOS THERAPIES - TERMINATION OF SALES AGREEMENT EFFECTIVE JULY 28, 2026 - SEC FILINGSource text: [ID:n0001213900-26-082876]Further company coverage:OSTX.A","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V25Z:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding,express","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655122028","title":"OS Therapies Ends At-The-Market Equity Sales Program","url":"https://stock-news.laohu8.com/highlight/detail?id=2655122028","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655122028?lang=en_us&edition=fundamental","pubTime":"2026-07-30 05:29","pubTimestamp":1785360584,"startTime":"0","endTime":"0","summary":"OS Therapies Incorporated ( ($OSTX) ) just unveiled an announcement. On July 23, 2026, OS Therapies Incorporated notified B. Riley Securities Inc. ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/os-therapies-ends-at-the-market-equity-sales-program?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/os-therapies-ends-at-the-market-equity-sales-program?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OSTX","EQR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2655149548","title":"Os Therapies - Termination of Sales Agreement Effective July 28, 2026 - SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2655149548","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2655149548?lang=en_us&edition=fundamental","pubTime":"2026-07-30 05:03","pubTimestamp":1785359004,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260729:nFWN43V25Z:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4139","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2654803219","title":"OS Therapies Announces Annual Shareholder Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2654803219","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2654803219?lang=en_us&edition=fundamental","pubTime":"2026-07-25 04:18","pubTimestamp":1784924283,"startTime":"0","endTime":"0","summary":"OS Therapies announces annual shareholder meetingOS Therapies will hold its annual shareholder meeting in a virtual format on Sept. 9, 2026.Shareholders will vote to elect six directors to serve until","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260724:nNDL3dZCqS:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2653776996","title":"OS Therapies Files Form 3 Showing Director Craig Eagle Holds no Securities","url":"https://stock-news.laohu8.com/highlight/detail?id=2653776996","media":"Reuters","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2653776996?lang=en_us&edition=fundamental","pubTime":"2026-07-24 04:46","pubTimestamp":1784839583,"startTime":"0","endTime":"0","summary":"OS Therapies files Form 3 showing director Craig Eagle holds no securitiesOS Therapies reported director Craig Eagle’s initial Form 3 filing dated July 1, 2026.Disclaimer:This news brief was created b","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260723:nNDL5JZNDJ:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650927081","title":"OS Therapies Initiated at Buy by Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2650927081","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650927081?lang=en_us&edition=fundamental","pubTime":"2026-07-09 22:04","pubTimestamp":1783605840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OSTX/analyst-ratings(END) Dow Jones NewswiresJuly 09, 2026 10:04 ET","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2650916925","title":"OS Therapies initiated with a Buy at Roth Capital","url":"https://stock-news.laohu8.com/highlight/detail?id=2650916925","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2650916925?lang=en_us&edition=fundamental","pubTime":"2026-07-09 18:40","pubTimestamp":1783593649,"startTime":"0","endTime":"0","summary":"Roth Capital analyst Adam Walsh initiated coverage of OS Therapies (OSTX) with a Buy rating and $7 price target The firm believes Listeria immunoth...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/os-therapies-initiated-with-a-buy-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/os-therapies-initiated-with-a-buy-at-roth-capital-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649967029","title":"OS Therapies Accepts FDA CDER Meeting Request to Review Ost-her2 Biomarker Data","url":"https://stock-news.laohu8.com/highlight/detail?id=2649967029","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649967029?lang=en_us&edition=fundamental","pubTime":"2026-07-08 21:09","pubTimestamp":1783516193,"startTime":"0","endTime":"0","summary":"OS Therapies accepts FDA CDER meeting request to review OST-HER2 biomarker dataOS Therapies accepted an FDA CDER meeting request to review patent-pending pharmacodynamic biomarker data for OST-HER2 un","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260708:nNDLbPs3hH:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649938908","title":"OS Therapies Amends 8-K to Add Side Letter Tied to Leonite Private Placement","url":"https://stock-news.laohu8.com/highlight/detail?id=2649938908","media":"Reuters","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649938908?lang=en_us&edition=fundamental","pubTime":"2026-07-07 21:19","pubTimestamp":1783430348,"startTime":"0","endTime":"0","summary":"OS Therapies amends 8-K to add side letter tied to Leonite private placementOS Therapies filed an amended Form 8-K to correct an omission in its July 2, 2026 report on a private placement.The amendmen","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260707:nNDL39N5Qm:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649386379","title":"OS Therapies Incorporated (OSTX) Gets a Buy from Lake Street","url":"https://stock-news.laohu8.com/highlight/detail?id=2649386379","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649386379?lang=en_us&edition=fundamental","pubTime":"2026-07-07 21:05","pubTimestamp":1783429534,"startTime":"0","endTime":"0","summary":"Lake Street analyst Chad Messer maintained a Buy rating on OS Therapies Incorporated today and set a price target of $13.00. Messer covers the Heal...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/os-therapies-incorporated-ostx-gets-a-buy-from-lake-street-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/os-therapies-incorporated-ostx-gets-a-buy-from-lake-street-blurbs-news-2?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2649684624","title":"OS Therapies Enters USD 10 Million Line of Credit Backed by U.K. VAT, R&D Tax Credits","url":"https://stock-news.laohu8.com/highlight/detail?id=2649684624","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2649684624?lang=en_us&edition=fundamental","pubTime":"2026-07-06 21:02","pubTimestamp":1783342930,"startTime":"0","endTime":"0","summary":"OS Therapies enters USD 10 million line of credit backed by U.K. VAT, R&D tax creditsOS Therapies entered a USD 10 million line of credit backed by VAT reimbursements and R&D tax credits at its UK sub","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260706:nNDL1rHv3K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648636845","title":"OS Therapies Secures Convertible Note Financing for Expansion","url":"https://stock-news.laohu8.com/highlight/detail?id=2648636845","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648636845?lang=en_us&edition=fundamental","pubTime":"2026-07-03 05:10","pubTimestamp":1783026652,"startTime":"0","endTime":"0","summary":"OS Therapies Incorporated ( ($OSTX) ) has issued an announcement. On June 30, 2026, OS Therapies and its subsidiaries entered a private placement w...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/os-therapies-secures-convertible-note-financing-for-expansion?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/os-therapies-secures-convertible-note-financing-for-expansion?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648363354","title":"Os Therapies - Enters Agreement for up to $10 Mln Senior Secured Convertible Note on June 30- SEC Filing","url":"https://stock-news.laohu8.com/highlight/detail?id=2648363354","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648363354?lang=en_us&edition=fundamental","pubTime":"2026-07-03 04:32","pubTimestamp":1783024367,"startTime":"0","endTime":"0","summary":null,"market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nFWN4340VF:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2648504477","title":"OS Therapies Names Chief Medical Advisor Craig Eagle to Board","url":"https://stock-news.laohu8.com/highlight/detail?id=2648504477","media":"Reuters","labels":["executive","shareholding"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2648504477?lang=en_us&edition=fundamental","pubTime":"2026-07-02 19:32","pubTimestamp":1782991926,"startTime":"0","endTime":"0","summary":"OS Therapies names Chief Medical Advisor Craig Eagle to boardOS Therapies appointed Chief Medical Advisor Craig Eagle to its board, replacing departing director Karim Galzahr, who will remain on the a","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260702:nNDLlcCpD:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive,shareholding","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2647558249","title":"OS Therapies Seeks FDA Alignment on 3-year Overall Survival Endpoint for Ost-her2 Accelerated Approval Bid","url":"https://stock-news.laohu8.com/highlight/detail?id=2647558249","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2647558249?lang=en_us&edition=fundamental","pubTime":"2026-06-30 19:41","pubTimestamp":1782819688,"startTime":"0","endTime":"0","summary":"OS Therapies seeks FDA alignment on 3-year overall survival endpoint for OST-HER2 accelerated approval bidOS Therapies requested an FDA Type B meeting to support an accelerated-approval filing for OST","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260630:nNDL1Bnqcb:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OSTX","BK4139"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2646541723","title":"OS Therapies Unit OS Animal Health Posts Peer-reviewed Data for Ost-her2 in Canine Osteosarcoma Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2646541723","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2646541723?lang=en_us&edition=fundamental","pubTime":"2026-06-26 19:41","pubTimestamp":1782474081,"startTime":"0","endTime":"0","summary":"OS Therapies unit OS Animal Health posts peer-reviewed data for OST-HER2 in canine osteosarcoma trialOS Animal Health, the wholly owned animal-health subsidiary of OS Therapies, reported peer-reviewed","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260626:nNDL4jD20J:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640590045","title":"Wall Street Analysts Are Bullish on Top Healthcare Picks","url":"https://stock-news.laohu8.com/highlight/detail?id=2640590045","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640590045?lang=en_us&edition=fundamental","pubTime":"2026-06-03 22:10","pubTimestamp":1780495808,"startTime":"0","endTime":"0","summary":"There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Axsome Therapeutics (AXSM) and OS Therapies Incorpor...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-204?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/wall-street-analysts-are-bullish-on-top-healthcare-picks-blurbs-news-204?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OSTX","BK4505","AXSM","BK4585","BK4139","BK4007"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2640911759","title":"OS Therapies says OST-HER2 Phase 2b trial posts 75% 2.5-year survival in resected metastatic osteosarcoma","url":"https://stock-news.laohu8.com/highlight/detail?id=2640911759","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2640911759?lang=en_us&edition=fundamental","pubTime":"2026-06-02 18:01","pubTimestamp":1780394516,"startTime":"0","endTime":"0","summary":"OS Therapies reported its Phase 2b OST-HER2 study in fully resected pulmonary metastatic osteosarcoma showed a clearer survival benefit versus historical comparisons.Updated findings have not yet been presented; detailed results are slated for release at a late-June 2026 osteosarcoma conference.The company is adding the updated data to regulatory filings, targeting early market authorizations across major Western markets in 2H 2026.Regulators in Europe and Australia have aligned on using upcoming 3-year survival results, expected in early Q4 2026, as a key endpoint.A confirmatory Phase 3 trial is expected to start in late Q3 2026 in Australia, a prerequisite for early market access.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260602:nNDL8y7q6M:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSTX"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2639624674","title":"OS Therapies to release 2.5-year overall survival data from Phase 2b OST-HER2 osteosarcoma trial at ASCO 2026","url":"https://stock-news.laohu8.com/highlight/detail?id=2639624674","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2639624674?lang=en_us&edition=fundamental","pubTime":"2026-05-29 19:21","pubTimestamp":1780053677,"startTime":"0","endTime":"0","summary":"OS Therapies flagged an upcoming release of 2.5-year overall survival results from its Phase 2b OST-HER2 osteosarcoma trial.Data will be presented at the 2026 ASCO Annual Meeting running May 28 to June 2, 2026; results have not yet been disclosed.The readout targets whether OST-HER2 can prevent or delay recurrence following full surgical removal of pulmonary metastatic osteosarcoma.The company reiterated plans to seek a U.S. accelerated-approval BLA in the second half of 2026, with parallel filings planned abroad.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260529:nNDLlzQ61:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","OSTX"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":2,"totalSize":69,"code":"91000000","status":"200"}]}}